Vir Biotechnology Inc (VIR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 835,870 | 861,312 | 976,690 | 1,518,330 | 826,757 |
| Marketable Securities | 1,425,162 | 1,553,409 | 1,382,746 | 690,520 | 447,719 |
| Receivables | N/A | N/A | N/A | 7,000 | 1,223,161 |
| TOTAL | $2,358,634 | $2,519,077 | $2,413,616 | $2,288,267 | $2,567,548 |
| Non-Current Assets | |||||
| PPE Net | 103,758 | 105,609 | 100,226 | 85,135 | 65,583 |
| Investments And Advances | 49,187 | 23,927 | 34,102 | 97,585 | 103,535 |
| Intangibles | 49,559 | 49,692 | 49,825 | 49,958 | 50,091 |
| Other Non-Current Assets | 104,798 | 103,783 | 98,201 | 98,049 | 100,372 |
| TOTAL | $307,302 | $283,011 | $282,354 | $330,727 | $319,581 |
| Total Assets | $2,665,936 | $2,802,088 | $2,695,970 | $2,618,994 | $2,887,129 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 12,149 | 6,422 | 2,722 | 10,618 | 10,955 |
| Accrued Expenses | 455,922 | 489,090 | 282,616 | 354,086 | 577,669 |
| TOTAL | $485,288 | $511,029 | $308,203 | $477,868 | $702,361 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 17,217 | 15,517 | 22,865 | 113,164 | 113,737 |
| Other Non-Current Liabilities | 153,443 | 159,889 | 164,820 | 166,256 | 159,450 |
| TOTAL | $209,847 | $213,096 | $237,912 | $189,114 | $183,754 |
| Total Liabilities | $695,135 | $724,125 | $546,115 | $666,982 | $886,115 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 133,977 | 133,531 | 133,116 | 132,638 | 132,376 |
| Common Shares | 13 | 13 | 13 | 13 | 13 |
| Retained earnings | 236,337 | 377,237 | 478,840 | 303,528 | 380,021 |
| Other shareholders' equity | -3,175 | -9,122 | -11,880 | -7,553 | -4,805 |
| TOTAL | $1,970,801 | $2,077,963 | $2,149,855 | $1,952,012 | $2,001,014 |
| Total Liabilities And Equity | $2,665,936 | $2,802,088 | $2,695,970 | $2,618,994 | $2,887,129 |